Placebo groups, by contrast, lost only 23% of their weight
10.1016/j.apsb.2021.04.001 Summary Keywords gastrointestinal barriers, intestinal permeability, oral bioavailability, oral peptide delivery, permeation enhancers, pharmacokinetics, solid dosage formulations, translational modeling Citation Khalid N-U-A, Rivera-Delgado E and von Erlach T (2026) Navigating the complexity of oral peptide delivery: challenges and strategies to enhance oral bioavailability
Meyer H, Goettlicher S, Mendling W
6,9 Individuals with T2D should be categorised into different CV risk groups ( Table 1 )
By the numbers, more than 40% of adults in the United States have obesity, to say nothing of the millions more who are overweight